Durect (DRRX): I don't think it's a start over this tim...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	59
Posts	18522
Boards Moderated	0
Alias Born	11/29/2006

realfast95

Re: north40000 post# 699

Saturday, 10/21/2017 9:50:39 AM

Saturday, October 21, 2017 9:50:39 AM

I don't think it's a start over this time.

The one piece of due diligence I missed came back to bite me.

When I listened to the recent investor presentations, and heard the road map for POSIMIR, they mentioned that FDA approval would take longer, because it's the second time around for this drug.
I was going to find out why it failed approval the first time, but never got around to it.

The CEO is 60 years old and the Chief Scientist Theeuwes is 79.
Somehow, I don't think his daughter the dentist, will be taking over.

Even if Pain Therapeutics can somehow get Remoxy approved. I see the competitor at EGLT which is approved, trading for $1

DRRX all of a sudden has a cash problem. POSIMER was supposed to pay for everything. And they even had a loan on it.

The next drug in the pipeline is many years away. These Bio companies are used to reverse splits and cash dilution.